Because of this prominence of TDP-43 pathology, and a general lack of deposition of the microtubule associated tau protein, the FTLD of ALS-FTD is currently classified as a “TDP-43 proteinopathy” and not a “tau proteinopathy.” This evidence concerns the gene TARDBP and frontotemporal dementia.